Teladoc (TDOC) Stock Slides as Market Rises: Facts to Know Before You Trade

Teladoc (TDOC) concluded the recent trading session at $6.28, signifying a -2.33% move from its prior day's close.

Zacks Investment Research • Sep 17, 2026

Teladoc: Integrated Care And Free Cash Flow Could Bring It Back To Life

Teladoc Health trades near multi-year lows, with the market pricing in deep distress despite meaningful free cash flow and manageable debt. BetterHelp's rapid decline drags on TDOC, but Integrated Care's improving margins and growing revenue per member offer stabilization. TDOC's valuation is extremely depressed, trading at just 7–8x expected free cash flow, with fair value estimates suggesting significant upside even under conservative scenarios.

Seeking Alpha • Sep 12, 2026

Why Teladoc (TDOC) Outpaced the Stock Market Today

Teladoc (TDOC) reached $6.16 at the closing of the latest trading day, reflecting a +1.15% change compared to its last close.

Zacks Investment Research • Sep 11, 2026

2 Beaten-Down Stocks to Avoid Right Now

Teladoc's business isn't making much progress, despite expanding insurance coverage within one of its most important segments. Recursion Pharmaceuticals claims that its approach to drug development is superior, but so far, it has yet to prove that claim.

The Motley Fool • Sep 8, 2026

Here's Why Teladoc's Integrated Care Business Deserves More Attention

TDOC's Integrated Care is driving profitability as chronic care gains traction, potentially making it the company's key earnings driver.

Zacks Investment Research • Sep 7, 2026

Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08

NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to a new employee.

GlobeNewsWire • Sep 3, 2026

Here's Why Investors Should Stay Neutral on TDOC Stock for Now

Teladoc Health's growth is supported by chronic care, international expansion and Teladoc One, but BetterHelp weakness and losses temper the outlook.

Zacks Investment Research • Sep 2, 2026

Teladoc appoints insurance executive Michael Grasher as CFO

Teladoc Health said on Monday it appointed Michael Grasher as its chief financial officer, bringing in an ​industry veteran to help the virtual healthcare company navigate ‌rising demand for its insurance-covered business.

Reuters • Aug 31, 2026

Teladoc Health Appoints Michael Grasher as Chief Financial Officer

Appointment brings seasoned financial leadership as Teladoc Health advances its strategy aimed at delivering disciplined, sustainable growth  NEW YORK, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Michael Grasher as Chief Financial Officer, effective immediately. Mr. Grasher is an accomplished financial executive with more than three decades of experience across the insurance and financial services sectors, including more than 12 years in CFO roles at public and privately held companies.

GlobeNewsWire • Aug 31, 2026

Teladoc (TDOC) Down 3.3% Since Last Earnings Report: Can It Rebound?

Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • Aug 28, 2026